EPHA3
Ephrin type-A receptor 3
Also known as: EPHA3_HUMAN, ETK, ETK1, HEK, HEK4, TYRO4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29320
- Gene
- EPHA3
- Ensembl
- ENSG00000044524
- Chromosome
- 3
- Canonical length
- 983 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
983 residues, UniProt reviewed canonical sequence.
>P29320|EPHA3
1 MDCQLSILLL LSCSVLDSFG ELIPQPSNEV NLLDSKTIQG ELGWISYPSH GWEEISGVDE
61 HYTPIRTYQV CNVMDHSQNN WLRTNWVPRN SAQKIYVELK FTLRDCNSIP LVLGTCKETF
121 NLYYMESDDD HGVKFREHQF TKIDTIAADE SFTQMDLGDR ILKLNTEIRE VGPVNKKGFY
181 LAFQDVGACV ALVSVRVYFK KCPFTVKNLA MFPDTVPMDS QSLVEVRGSC VNNSKEEDPP
241 RMYCSTEGEW LVPIGKCSCN AGYEERGFMC QACRPGFYKA LDGNMKCAKC PPHSSTQEDG
301 SMNCRCENNY FRADKDPPSM ACTRPPSSPR NVISNINETS VILDWSWPLD TGGRKDVTFN
361 IICKKCGWNI KQCEPCSPNV RFLPRQFGLT NTTVTVTDLL AHTNYTFEID AVNGVSELSS
421 PPRQFAAVSI TTNQAAPSPV LTIKKDRTSR NSISLSWQEP EHPNGIILDY EVKYYEKQEQ
481 ETSYTILRAR GTNVTISSLK PDTIYVFQIR ARTAAGYGTN SRKFEFETSP DSFSISGESS
541 QVVMIAISAA VAIILLTVVI YVLIGRFCGY KSKHGADEKR LHFGNGHLKL PGLRTYVDPH
601 TYEDPTQAVH EFAKELDATN ISIDKVVGAG EFGEVCSGRL KLPSKKEISV AIKTLKVGYT
661 EKQRRDFLGE ASIMGQFDHP NIIRLEGVVT KSKPVMIVTE YMENGSLDSF LRKHDAQFTV
721 IQLVGMLRGI ASGMKYLSDM GYVHRDLAAR NILINSNLVC KVSDFGLSRV LEDDPEAAYT
781 TRGGKIPIRW TSPEAIAYRK FTSASDVWSY GIVLWEVMSY GERPYWEMSN QDVIKAVDEG
841 YRLPPPMDCP AALYQLMLDC WQKDRNNRPK FEQIVSILDK LIRNPGSLKI ITSAAARPSN
901 LLLDQSNVDI TTFRTTGDWL NGVWTAHCKE IFTGVEYSSC DTIAKISTDD MKKVGVTVVG
961 PQKKIISSIK ALETQSKNGP VPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- prostate: 30 nTPM
- placenta: 19 nTPM
- gallbladder: 18 nTPM
- urinary bladder: 13 nTPM
- cervix: 12 nTPM
- thyroid gland: 10 nTPM
Single-cell type
- retinal horizontal cells: 361 nCPM
- corticotrophs: 300 nCPM
- rod photoreceptor cells: 297 nCPM
- fibro-adipogenic progenitors: 210 nCPM
- pericytes: 166 nCPM
- vascular smooth muscle cells: 133 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 13 nTPM
- cerebral cortex: 12 nTPM
- amygdala: 8.7 nTPM
- white matter: 8.7 nTPM
- thalamus: 8 nTPM
- medulla oblongata: 7.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EPHA3.
Disease | AllUniProt
Conditions EPHA3 is implicated in, by any mechanism.
- Colorectal cancer (CRC) MIM:114500
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- cell adhesion
- cell migration
- cellular response to retinoic acid
- ephrin receptor signaling pathway
- fasciculation of motor neuron axon
- fasciculation of sensory neuron axon
- negative regulation of endocytosis
- negative regulation of epithelial to mesenchymal transition
- peptidyl-tyrosine phosphorylation
- positive regulation of neuron projection development
- positive regulation of protein localization to plasma membrane
- regulation of actin cytoskeleton organization
- regulation of cell-cell adhesion
- regulation of epithelial to mesenchymal transition
- regulation of focal adhesion assembly
- regulation of GTPase activity
- regulation of microtubule cytoskeleton organization
Molecular functions
- ATP binding
- ephrin receptor activity
- GPI-linked ephrin receptor activity
- transmembrane-ephrin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Ephrin, ligand binding domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, receptor class V, conserved site
- Sterile alpha motif domain
- Fibronectin type III
- Tyrosine-protein kinase, active site
- Galactose-binding-like domain superfamily
- Growth factor receptor cysteine-rich domain superfamily
- Protein kinase-like domain superfamily
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Sterile alpha motif/pointed domain superfamily
- Immunoglobulin-like fold
- Ephrin receptor type-A /type-B
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- Ephrin, transmembrane domain
- Fibronectin type III superfamily
- Ephrin receptor tyrosine kinases
- Fibronectin type III domain
- Ephrin receptor ligand binding domain
- SAM domain (Sterile alpha motif)
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Protein tyrosine and serine/threonine kinase
- Ephrin type-A receptor 2 transmembrane domain
- Ephrin cysteine rich domain
- Ephrin type-A receptor 3, ligand binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EPHA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHA3 as an antibody target. Whether an autoantibody or antibody against EPHA3 could matter depends on whether native EPHA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHA3 is annotated at the cell surface, where native EPHA3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EPHA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...